A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Status:
RECRUITING

Trial end date:
2029-12-14

Target enrollment:

Participant gender:

This study is being conducted to evaluate the safety and tolerability of INCA035784 in participants with myeloproliferative neoplasms.

PHASE1

Incyte Corporation